Article: Interleukin-2 induces NF-κB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells
| Title | Interleukin-2 induces NF-κB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells | ||||
|---|---|---|---|---|---|
| Authors | Chan, KK1 Shen, L1 Au, WY1 Yuen, HF1 Wong, KY1 Guo, T1 Wong, MLY1 Shimizu, N2 Tsuchiyama, J3 Kwong, YL1 Liang, RHS1 Srivastava, G1 | ||||
| Keywords | B BCL10 IL2 NF-κ NK cell lymphoma Nucleus | ||||
| Issue Date | 2010 | ||||
| Publisher | John Wiley & Sons. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/1130 | ||||
| Citation | Journal Of Pathology, 2010, v. 221 n. 2, p. 164-174 [How to Cite?] DOI: http://dx.doi.org/10.1002/path.2699 | ||||
| Abstract | Deregulation of nuclear factor (NF)-κB signalling is common in cancers and is essential for tumourigenesis. Constitutive NF-κB activation in extranodal natural killer (NK)-cell lymphoma, nasal type (ENKL) is known to be associated with aberrant nuclear translocation of BCL10. Here we investigated the mechanisms leading to NF-κB activation and BCL10 nuclear localization in ENKLs. Given that ENKLs are dependent on T-cell-derived interleukin-2 (IL2) for cytotoxicity and proliferation, we investigated whether IL2 modulates NF-κB activation and BCL10 subcellular localization in ENKLs. In the present study, IL2-activated NK lymphoma cells were found to induce NF-κB activation via the PI3K/Akt pathway, leading to an increase in the entry of G 2/M phase and concomitant transcription of NF-κB-responsive genes. We also found that BCL10, a key mediator of NF-κB signalling, participates in the cytokine receptor-induced activation of NF-κB. Knockdown of BCL10 expression resulted in deficient NF-κB signalling, whereas Akt activation was unaffected. Our results suggest that BCL10 plays a role downstream of Akt in the IL2-triggered NF-κB signalling pathway. Moreover, the addition of IL2 to NK cells led to aberrant nuclear translocation of BCL10, which is a pathological feature of ENKLs. We further show that BCL10 can bind to BCL3, a transcriptional co-activator and nuclear protein. Up-regulation of BCL3 expression was observed in response to IL2. Similar to BCL10, the expression and nuclear translocation of BCL3 were induced by IL2 in an Akt-dependent manner. The nuclear translocation of BCL10 was also dependent on BCL3 because silencing BCL3 by RNA interference abrogated this translocation. We identified a critical role for BCL10 in the cytokine receptor-induced NF-κB signalling pathway, which is essential for NK cell activation. We also revealed the underlying mechanism that controls BCL10 nuclear translocation in NK cells. Our findings provide insight into a molecular network within the NF-κB signalling pathway that promotes the pathogenesis of NK cell lymphomas. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. | ||||
| ISSN | 0022-3417 2011 Impact Factor: 6.318 2011 SCImago Journal Rankings: 0.946 | ||||
| DOI | http://dx.doi.org/10.1002/path.2699 | ||||
| ISI Accession Number ID | WOS:000278209800006
Funding Information: This study was supported by the General Research Fund (GRF) of the Research Grants Council of Hong Kong, China (HKU 7583/54M to GS and RHS). | ||||
| References | References in Scopus |
| dc.contributor.author | Chan, KK | ||||
|---|---|---|---|---|---|
| dc.contributor.author | Shen, L | ||||
| dc.contributor.author | Au, WY | ||||
| dc.contributor.author | Yuen, HF | ||||
| dc.contributor.author | Wong, KY | ||||
| dc.contributor.author | Guo, T | ||||
| dc.contributor.author | Wong, MLY | ||||
| dc.contributor.author | Shimizu, N | ||||
| dc.contributor.author | Tsuchiyama, J | ||||
| dc.contributor.author | Kwong, YL | ||||
| dc.contributor.author | Liang, RHS | ||||
| dc.contributor.author | Srivastava, G | ||||
| dc.date.accessioned | 2012-05-29T06:14:09Z | ||||
| dc.date.available | 2012-05-29T06:14:09Z | ||||
| dc.date.issued | 2010 | ||||
| dc.description.abstract | Deregulation of nuclear factor (NF)-κB signalling is common in cancers and is essential for tumourigenesis. Constitutive NF-κB activation in extranodal natural killer (NK)-cell lymphoma, nasal type (ENKL) is known to be associated with aberrant nuclear translocation of BCL10. Here we investigated the mechanisms leading to NF-κB activation and BCL10 nuclear localization in ENKLs. Given that ENKLs are dependent on T-cell-derived interleukin-2 (IL2) for cytotoxicity and proliferation, we investigated whether IL2 modulates NF-κB activation and BCL10 subcellular localization in ENKLs. In the present study, IL2-activated NK lymphoma cells were found to induce NF-κB activation via the PI3K/Akt pathway, leading to an increase in the entry of G 2/M phase and concomitant transcription of NF-κB-responsive genes. We also found that BCL10, a key mediator of NF-κB signalling, participates in the cytokine receptor-induced activation of NF-κB. Knockdown of BCL10 expression resulted in deficient NF-κB signalling, whereas Akt activation was unaffected. Our results suggest that BCL10 plays a role downstream of Akt in the IL2-triggered NF-κB signalling pathway. Moreover, the addition of IL2 to NK cells led to aberrant nuclear translocation of BCL10, which is a pathological feature of ENKLs. We further show that BCL10 can bind to BCL3, a transcriptional co-activator and nuclear protein. Up-regulation of BCL3 expression was observed in response to IL2. Similar to BCL10, the expression and nuclear translocation of BCL3 were induced by IL2 in an Akt-dependent manner. The nuclear translocation of BCL10 was also dependent on BCL3 because silencing BCL3 by RNA interference abrogated this translocation. We identified a critical role for BCL10 in the cytokine receptor-induced NF-κB signalling pathway, which is essential for NK cell activation. We also revealed the underlying mechanism that controls BCL10 nuclear translocation in NK cells. Our findings provide insight into a molecular network within the NF-κB signalling pathway that promotes the pathogenesis of NK cell lymphomas. Copyright © 2010 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd. | ||||
| dc.description.nature | Link_to_subscribed_fulltext | ||||
| dc.identifier.citation | Journal Of Pathology, 2010, v. 221 n. 2, p. 164-174 [How to Cite?] DOI: http://dx.doi.org/10.1002/path.2699 | ||||
| dc.identifier.doi | http://dx.doi.org/10.1002/path.2699 | ||||
| dc.identifier.epage | 174 | ||||
| dc.identifier.isi | WOS:000278209800006
Funding Information: This study was supported by the General Research Fund (GRF) of the Research Grants Council of Hong Kong, China (HKU 7583/54M to GS and RHS). | ||||
| dc.identifier.issn | 0022-3417 2011 Impact Factor: 6.318 2011 SCImago Journal Rankings: 0.946 | ||||
| dc.identifier.issue | 2 | ||||
| dc.identifier.pmid | 20235165 | ||||
| dc.identifier.scopus | eid_2-s2.0-77952769635 | ||||
| dc.identifier.spage | 164 | ||||
| dc.identifier.uri | http://hdl.handle.net/10722/148621 | ||||
| dc.identifier.volume | 221 | ||||
| dc.language | eng | ||||
| dc.publisher | John Wiley & Sons. The Journal's web site is located at http://www3.interscience.wiley.com/cgi-bin/jhome/1130 | ||||
| dc.publisher.place | United Kingdom | ||||
| dc.relation.ispartof | Journal of Pathology | ||||
| dc.relation.references | References in Scopus | ||||
| dc.subject.mesh | Adaptor Proteins, Signal Transducing - Genetics - Metabolism | ||||
| dc.subject.mesh | Cell Line | ||||
| dc.subject.mesh | Cell Nucleus - Metabolism | ||||
| dc.subject.mesh | Gene Expression Regulation - Genetics | ||||
| dc.subject.mesh | Humans | ||||
| dc.subject.mesh | Interleukin-2 - Pharmacology - Physiology | ||||
| dc.subject.mesh | Lymphoma, Extranodal Nk-T-Cell - Metabolism | ||||
| dc.subject.mesh | Nf-Kappa B - Genetics - Metabolism | ||||
| dc.subject.mesh | Proto-Oncogene Proteins - Metabolism | ||||
| dc.subject.mesh | Proto-Oncogene Proteins C-Akt - Metabolism | ||||
| dc.subject.mesh | Signal Transduction - Genetics | ||||
| dc.subject.mesh | Transcription Factors - Metabolism | ||||
| dc.subject | B | ||||
| dc.subject | BCL10 | ||||
| dc.subject | IL2 | ||||
| dc.subject | NF-κ | ||||
| dc.subject | NK cell lymphoma | ||||
| dc.subject | Nucleus | ||||
| dc.title | Interleukin-2 induces NF-κB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells | ||||
| dc.type | Article |
Author Affiliations
- The University of Hong Kong
- Tokyo Medical and Dental University
- Kawasaki Medical College

